Recent publications · Crossref
5 total works indexed
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
· 2017 · cited 6,733x
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
· 2019 · cited 5,470x
- Worldwide access to treatment for end-stage kidney disease: a systematic review
· 2015 · cited 2,034x
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
· 2024 · cited 1,682x
- Chronic kidney disease
· 2021 · cited 1,360x
via Crossref · CC0